Enhancing Lifestyles in the Metabolic Syndrome (ELM) Multi-Site Behavioral Efficacy Trial. Design and Baseline Cohort
Description
Prevalence of metabolic syndrome (MetS) increased from one-quarter to one-third of the United States (U.S.) adult population over 8 years. Diagnosed when ≥3 out of 5 cardiometabolic risk factors are present, there is widespread agreement that its